Evaluation of Intranasal Naltrexone and Naloxone
Phase 1
Completed
- Conditions
- Opioid-use Disorder
- Interventions
- First Posted Date
- 2019-02-22
- Last Posted Date
- 2020-09-14
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 12
- Registration Number
- NCT03851731
Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder
Recruiting
- Conditions
- Opioid-Related DisordersDrug Addiction
- First Posted Date
- 2018-11-19
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 150
- Registration Number
- NCT03745339
- Locations
- πΊπΈ
National Institute on Drug Abuse, Baltimore, Maryland, United States
State and Trait Mediated Response to TMS in Substance Use Disorder
Not Applicable
Withdrawn
- Conditions
- Nicotine Dependence
- Interventions
- Device: TMS
- First Posted Date
- 2018-10-16
- Last Posted Date
- 2020-06-16
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT03707600
- Locations
- πΊπΈ
National Institute on Drug Abuse, Baltimore, Maryland, United States
Just-In-Time Adaptive Interventions for Addictive Behaviors
Phase 2
Suspended
- Conditions
- Addiction
- Interventions
- Other: PlaceboBehavioral: JITAI
- First Posted Date
- 2018-05-29
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 9
- Registration Number
- NCT03538652
- Locations
- πΊπΈ
National Institute on Drug Abuse, Baltimore, Maryland, United States
Imaging Biomarker for Addiction Treatment Outcome
Terminated
- Conditions
- Alcohol-Related DisordersOpioid-Related Disorders
- First Posted Date
- 2018-02-09
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 52
- Registration Number
- NCT03427424
- Locations
- πΊπΈ
National Institute on Drug Abuse, Baltimore, Maryland, United States
Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam
Phase 1
Completed
- Conditions
- Cannabis Use Disorder
- Interventions
- First Posted Date
- 2018-01-12
- Last Posted Date
- 2018-06-14
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 42
- Registration Number
- NCT03398083
- Locations
- πΊπΈ
Debra Kelsh, MD, Overland Park, Kansas, United States
Mechanism of Non-invasive Magnetic Stimulation
Not Applicable
Recruiting
- Conditions
- Healthy Volunteers
- Interventions
- Device: TMS (MagVenture MagPro 100 with MagOption)
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 70
- Registration Number
- NCT03394066
- Locations
- πΊπΈ
National Institute on Drug Abuse, Baltimore, Maryland, United States
Comparison of Naloxone Pharmacokinetics
Phase 1
Completed
- Conditions
- Opioid-use Disorder
- Interventions
- Device: Mucosal atomization device and syringeDevice: NarcanDevice: Intramuscular Auto Injector
- First Posted Date
- 2017-12-29
- Last Posted Date
- 2018-03-09
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 30
- Registration Number
- NCT03386591
- Locations
- πΊπΈ
Vince and Associates Clinical Research, Overland Park, Kansas, United States
Exploring Gut-Brain and Brain-Gut Interactions in Alcohol Use Disorder Via Microbiota Investigations: A Pilot Study
Completed
- Conditions
- Alcoholism
- First Posted Date
- 2017-05-15
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 35
- Registration Number
- NCT03152760
- Locations
- πΊπΈ
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers
- First Posted Date
- 2017-04-26
- Last Posted Date
- 2018-03-26
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 14
- Registration Number
- NCT03129347
- Locations
- πΊπΈ
Vince and Associates Clinical Research, Overland Park, Kansas, United States
Β© Copyright 2025. All Rights Reserved by MedPath